Scottish biotech TC BioPharm lowers deal size by 40%, adds warrants ahead of $30 million US IPO<blockquote>苏格兰生物技术TC BioPharm将交易规模降低40%,并在3000万美元美国IPO前增加认股权证</blockquote>
Scottish biotech TC BioPharm lowers deal size by 40%, adds warrants ahead of $30 million US IPO<blockquote>苏格兰生物技术TC BioPharm将交易规模降低40%,并在3000万美元美国IPO前增加认股权证</blockquote>
Novartis jumped over 3% in premarket trading as it launched new shares buyback of up to $15 bln<blockquote>诺华启动高达150亿美元的新股回购,盘前交易中股价上涨超过3%</blockquote>